← Back to Clinical Trials
Recruiting NCT07724925

NCT07724925 Comparative Effects of Task-Oriented Training and Hand-Arm Bimanual Intensive in Post-Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07724925
Status Recruiting
Phase
Sponsor Riphah International University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-06-01
Primary Completion 2026-07-30

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Task-Oriented TrainingHand-Arm Bimanual Intensive Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-06-01 with a primary completion date of 2026-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Stroke is a rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than a vascular origin. Among various rehabilitation strategies, Task-oriented training of low to moderate intensity and Hand-Arm bimanual intensive therapy have shown their promising results in stroke rehabilitation. So, this study aims to determine the comparative effects of Task-oriented and Hand-Arm bimanual intensive therapy on Gross and Fine motor skills of Upper Limb and Activities of Daily Living in Post-Stroke Patients.

Eligibility Criteria

Inclusion Criteria: * • Age 45-70 * Gender (both male and female) * Pre diagnosed First-time stroke patients (ischemic or hemorrhagic) * Time since stroke: ≥3 months * Mild to moderate upper limb impairment (ABILHAND Questionnaire: Less than 50% of items rated as "impossible.") * Moderate functional independence in basic activities (Barthel Index score ≥ 60) * Ability to follow commands (MMSE \> 24 or equivalent cognitive screening) Exclusion Criteria: * • Severe spasticity (Modified Ashworth Scale score ≥ 3) or contractures * Other neurological conditions (Alzheimer's disease, Parkinson and dementia) * Unstable medical conditions (diabetes and hypertension) that may interfere with participation * Participation in any other structured upper limb rehabilitation or experimental therapy within the past 3 months

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

Aiza Yousaf, MS-OMPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07724925 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07724925 currently recruiting?

Yes, NCT07724925 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07724925 trial being conducted?

This trial is being conducted at Nankana Sahib, Pakistan.

Who is sponsoring the NCT07724925 clinical trial?

NCT07724925 is sponsored by Riphah International University. The principal investigator is Aiza Yousaf, MS-OMPT at Riphah International University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology